Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health

Russell Rosenblatt, Hannah Lee, AnnMarie Liapakis, Keri E. Lunsford, Andrew Scott, Pratima Sharma, Julius Wilder – 31 May 2021 – The COVID‐19 pandemic and social justice movement have highlighted the impact of social determinants of health (SDOH) and structural racism in the United States on both access to care and patient outcomes. With the evaluation for liver transplantation being a highly subjective process, there are multiple ways for SDOH to place vulnerable patients at a disadvantage.

Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health

Russell Rosenblatt, Hannah Lee, AnnMarie Liapakis, Keri E. Lunsford, Andrew Scott, Pratima Sharma, Julius Wilder – 31 May 2021 – The COVID‐19 pandemic and social justice movement have highlighted the impact of social determinants of health (SDOH) and structural racism in the United States on both access to care and patient outcomes. With the evaluation for liver transplantation being a highly subjective process, there are multiple ways for SDOH to place vulnerable patients at a disadvantage.

We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases

Brian T. Lee, Michele M. Tana, Jeffrey A. Kahn, Lily Dara – 30 May 2021 – Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and environmental factors. Increased prevalence, later stage at presentation, worse response to standard therapy, and transplant‐related disparities have all been reported in racial and ethnic minorities such as Black and Latinx patients with autoimmune liver diseases.

Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time

Ioannis A. Ziogas, W. Kelly Wu, Lea K. Matsuoka, Anita K. Pai, Einar T. Hafberg, Lynette A. Gillis, Thomas M. Morgan, Sophoclis P. Alexopoulos – 30 May 2021 – Liver transplantation (LT) for children with urea cycle disorders (UCDs) is capable of correcting the enzymatic defect and preventing progressive neurologic injury. We describe the characteristics and outcomes of pediatric LT recipients with UCDs. We identified all pediatric (<18 years) LT candidates with UCDs in the United Network for Organ Sharing (UNOS) database (February 2002 to September 2020).

We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases

Brian T. Lee, Michele M. Tana, Jeffrey A. Kahn, Lily Dara – 30 May 2021 – Autoimmune liver diseases are attributed to a complex interplay of biologic, acquired, and environmental factors. Increased prevalence, later stage at presentation, worse response to standard therapy, and transplant‐related disparities have all been reported in racial and ethnic minorities such as Black and Latinx patients with autoimmune liver diseases.

Donor Morbidity Is Equivalent Between Right and Left Hepatectomy for Living Liver Donation: A Meta‐Analysis

Paola A. Vargas, Emily K.E. McCracken, Indika Mallawaarachchi, Sarah J. Ratcliffe, Curtis Argo, Shawn Pelletier, Victor M. Zaydfudim, Jose Oberholzer, Nicolas Goldaracena – 29 May 2021 – Maximizing liver graft volume benefits the living donor liver recipient. Whether maximizing graft volume negatively impacts living donor recovery and outcomes remains controversial.

Subscribe to